HomeCompareMBII vs JEPQ

MBII vs JEPQ: Dividend Comparison 2026

MBII yields 250.60% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MBII wins by $467.83M in total portfolio value
10 years
MBII
MBII
● Live price
250.60%
Share price
$0.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$467.88M
Annual income
$262,117,387.00
Full MBII calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — MBII vs JEPQ

📍 MBII pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMBIIJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MBII + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MBII pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MBII
Annual income on $10K today (after 15% tax)
$21,300.59/yr
After 10yr DRIP, annual income (after tax)
$222,799,778.95/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, MBII beats the other by $222,797,949.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MBII + JEPQ for your $10,000?

MBII: 50%JEPQ: 50%
100% JEPQ50/50100% MBII
Portfolio after 10yr
$233.96M
Annual income
$131,059,769.79/yr
Blended yield
56.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MBII right now

MBII
Analyst Ratings
5
Buy
3
Hold
Consensus: Buy
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MBII buys
0
JEPQ buys
0
No recent congressional trades found for MBII or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMBIIJEPQ
Forward yield250.60%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$467.88M$44.8K
Annual income after 10y$262,117,387.00$2,152.59
Total dividends collected$445.94M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: MBII vs JEPQ ($10,000, DRIP)

YearMBII PortfolioMBII Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$35,760$25,059.52$11,930$1,110.39+$23.8KMBII
2$122,012$83,749.18$14,133$1,224.34+$107.9KMBII
3$397,612$267,058.97$16,632$1,340.46+$381.0KMBII
4$1,238,800$813,355.61$19,454$1,457.97+$1.22MMBII
5$3,693,827$2,368,311.37$22,626$1,576.08+$3.67MMBII
6$10,552,190$6,599,794.32$26,175$1,694.09+$10.53MMBII
7$28,911,115$17,620,272.02$30,133$1,811.32+$28.88MMBII
8$76,053,022$45,118,129.07$34,531$1,927.17+$76.02MMBII
9$192,299,052$110,922,318.76$39,403$2,041.08+$192.26MMBII
10$467,877,373$262,117,387.00$44,787$2,152.59+$467.83MMBII

MBII vs JEPQ: Complete Analysis 2026

MBIIStock

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.

Full MBII Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this MBII vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MBII vs SCHDMBII vs JEPIMBII vs OMBII vs KOMBII vs MAINMBII vs XYLDMBII vs QYLDMBII vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.